Tuesday, December 07, 2021 9:06:23 AM
MINUTES OF EXTRAORDINARY GENERAL MEETING HELD ON 3RD and 6TH OF DECEMBER 2021 AT 7:30 PM. VIA ONLINE MEETING.
LHGI made an effort to connect and to explore synergies with another Public Listed Company, Raffles Financial Group. Listed in OTC Markets (OTCQX: RAFFF) and Canadian Stocks Exchange (CSE: RICH).
Website: https://www.rafflesfinancial.co/
Dr. Charlie In is currently the Chairman of Raffles Financial Group. You may find his CV at the bottom of the page for your reference.
As a majority shareholder of RICH/RAFFF, Dr. In has proposed to explore opportunities between RAFFF and LHGI.
On a personal gesture for an alignment of interest, Charlie has agreed to acquire some of your LHGI Shares using his RAFFF Shares.
The swap of LHGI Shares to RAFFF is based on a 370:1 ratio.
The terms and conditions will be stated on a more definitive Sales & Purchase Agreement for all who are keen to accept his offer.
His personal offer is subjected to
His general offer is subjected to:
1) a minimum acquisition of 20% LHGI shares, up to a maximum of 29.9%, and
2) a minimum number of 175 shareholders.
Should any of the 2 criteria are not attained, this offer will be nullified and void, unless Dr. In gives an exception.
Our hope is for Dr. In to own more than 20% of LHGI.
Once the above proposal is confirmed and signed,
Raffles Group will inject capital of up to $1M to LHGI to sustain and to embark on its new business plans. The fund injection will help LHGI to be audited, and to be SEC Full Reporting, so we can qualify for an upgrade to OTCQB.
The following are the business activities proposed for LHGI to embark on:
Enabling Projagg Live
REDV Fund in a joint venture with Passion Venture Capital, whereby LHGI will be acting as its Co-General Partner (www.redinasia.com)
Acquisition of Raffles EMI Pte Ltd - advisory in tokenized trade finance, tokenized customer loyalty programs, digital asset exchange IPO
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM